Daniel Chen
Partner & Co-Founder Genesis BioCapital
Seminars
Wednesday 5th November 2025
Lessons From ADC Clinical Trials: Exploring Human Biology, “Synthetic Lethality” & Future ADC Design
11:00 am
- Reviewing the successes and failures for ADCs in the clinic in categories across target, indication, ADC design and linker payload
- Understanding implications for human biology and how this relates to improvement opportunities for ADCs
- Laying out lessons for mechanism of action of ORR versus CR/DOR
